Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Astellas has expanded its business in South East Europe, by establishing a new subsidiary, Astellas Pharma d.o.o. in Slovenia.
Subscribe to our email newsletter
The new subsidiary will be engaged on marketing and selling Astellas‘ global products like Omnic and OmnicOCAS as a tretamnet for functional symptoms of benign prostatic hyperplasia.
Additionally, the company will also market Vesicare for the treatment of overactive bladder, Protopic for the treatment of atopic dermatitis and Prograf/ Advagraf, an immunosuppressant.
Earlier in 2009, the company has established wholly-owned subsidiaries in Romania and Bulgaria.
Astellas South East Europe will manage the business in Romania and Bulgaria, as well as Slovenia, Croatia, and some operations in Bosnia-Herzegovina, as one regional organisation.